Arcellx, Inc. - Common Stock $0.001 par value per share (ACLX)

CUSIP: 03940C100

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock $0.001 par value per share
Shares outstanding
100
Total 13F shares
60,837,024
Share change
-713,117
Total reported value
$4,006,426,303
Put/Call ratio
361%
Price per share
$65.85
Number of holders
200
Value change
-$46,745,437
Number of buys
90
Number of sells
106

Quarterly Holders Quick Answers

What is CUSIP 03940C100?
CUSIP 03940C100 identifies ACLX - Arcellx, Inc. - Common Stock $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ACLX - Arcellx, Inc. - Common Stock $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
GILEAD SCIENCES, INC.
13F 3/4/5
Company · 10%+ Owner
6720803%
6,720,803
$440,884,677 31 Mar 2025
FMR LLC
13F
Company
6303679%
6,303,679
$413,521,372 31 Mar 2025
13F
Paradigm Biocapital Advisors LP
13F
Company
4492032%
4,492,032
$294,677,299 31 Mar 2025
13F
NEA Partners 15, L.P.
3/4/5
10%+ Owner
class O/S missing
4,745,262
$262,260,666 20 Dec 2022
New Enterprise Associates 15, L.P.
3/4/5
10%+ Owner
class O/S missing
4,745,262
$262,260,666 20 Dec 2022
VANGUARD GROUP INC
13F
Company
3985156%
3,985,156
$261,426,232 31 Mar 2025
13F
BlackRock, Inc.
13F 13D/G
Company
6.4%
from 13D/G
3,967,569
$260,272,493 31 Mar 2025
NEA Management Company, LLC
13F
Company
3745262%
3,745,262
$245,689,187 31 Mar 2025
13F
Novo Holdings A/S
3/4/5
10%+ Owner
class O/S missing
4,016,878
$222,004,412 08 Feb 2022
RA CAPITAL MANAGEMENT, L.P.
13F
Company
3036527%
3,036,527
$199,196,171 31 Mar 2025
13F
PERCEPTIVE ADVISORS LLC
13F 13D/G
Company
4.5%
from 13D/G
2,926,478
$191,976,957 31 Mar 2025
Vestal Point Capital, LP
13F
Company
2387720%
2,387,720
$156,634,432 31 Mar 2025
13F
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
2346630%
2,346,630
$153,938,928 31 Mar 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1839624%
1,839,624
$120,680,000 31 Mar 2025
13F
Lewis T. "rusty" Williams
3/4/5
Director
class O/S missing
2,095,114
$115,792,551 08 Feb 2022
STATE STREET CORP
13F
Company
1666451%
1,666,451
$109,319,186 31 Mar 2025
13F
T. Rowe Price Investment Management, Inc.
13F
Company
1665138%
1,665,138
$109,234,000 31 Mar 2025
13F
JANUS HENDERSON GROUP PLC
13F
Company
1510494%
1,510,494
$102,640,816 31 Mar 2025
13F
SR ONE CAPITAL MANAGEMENT, LLC
3/4/5
10%+ Owner
class O/S missing
1,658,780
$91,677,287 11 May 2023
Cormorant Asset Management, LP
13F
Company
1050000%
1,050,000
$68,880,000 31 Mar 2025
13F
AJU IB Investment Co., Ltd.
13F
Company
1047557%
1,047,557
$68,719,739 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1020540%
1,020,540
$66,961,662 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
726127%
726,127
$47,633,931 31 Mar 2025
13F
Capital World Investors
13F
Company
709374%
709,374
$46,534,934 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
683581%
683,581
$44,842,913 31 Mar 2025
13F
LORD, ABBETT & CO. LLC
13F
Company
664526%
664,526
$43,593,000 31 Mar 2025
13F
Affinity Asset Advisors, LLC
13F
Company
530000%
530,000
$34,768,000 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
486269%
486,269
$31,903,935 31 Mar 2025
13F
BAMCO INC /NY/
13F
Company
467261%
467,261
$30,652,322 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
462333%
462,333
$30,329,136 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
403841%
403,841
$26,491,969 31 Mar 2025
13F
DEUTSCHE BANK AG\
13F
Company
343694%
343,694
$22,546,326 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
336949%
336,949
$22,103,854 31 Mar 2025
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
277102%
277,102
$18,177,891 31 Mar 2025
13F
STEMPOINT CAPITAL LP
13F
Company
273774%
273,774
$17,959,574 31 Mar 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
264756%
264,756
$17,367,994 31 Mar 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
233522%
233,522
$15,319,041 31 Mar 2025
13F
Artia Global Partners LP
13F
Company
229085%
229,085
$15,027,976 31 Mar 2025
13F
UBS Group AG
13F
Company
209572%
209,572
$13,747,923 31 Mar 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
178110%
178,110
$11,684,016 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
174788%
174,788
$11,466,092 31 Mar 2025
13F
Qube Research & Technologies Ltd
13F
Company
173059%
173,059
$11,352,670 31 Mar 2025
13F
TD ASSET MANAGEMENT INC
13F
Company
168320%
168,320
$11,041,792 31 Mar 2025
13F
Woodline Partners LP
13F
Company
165305%
165,305
$10,844,008 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
163670%
163,670
$10,736,752 31 Mar 2025
13F
Soleus Capital Management, L.P.
13F
Company
153031%
153,031
$10,038,834 31 Mar 2025
13F
Russell Investments Group, Ltd.
13F
Company
152023%
152,023
$9,972,717 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
143617%
143,617
$9,421,276 31 Mar 2025
13F
Samsara BioCapital, LLC
13F
Company
135276%
135,276
$8,874,106 31 Mar 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
128778%
128,778
$8,447,837 31 Mar 2025
13F

Institutional Holders of Arcellx, Inc. - Common Stock $0.001 par value per share (ACLX) as of Q2 2025

As of 30 Jun 2025, Arcellx, Inc. - Common Stock $0.001 par value per share (ACLX) was held by 200 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,837,024 shares. The largest 10 holders included GILEAD SCIENCES, INC., FMR LLC, Paradigm Biocapital Advisors LP, VANGUARD GROUP INC, NEA Management Company, LLC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, PERCEPTIVE ADVISORS LLC, and SR One Capital Management, LP. This page lists 201 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
195
Q2 2025 holders
200
Holder diff
5
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .